220 related articles for article (PubMed ID: 35348930)
1. Hypocomplementemia in primary Sjogren's syndrome: association with serological, clinical features, and outcome.
Lin W; Xin Z; Wang J; Ren X; Liu Y; Yang L; Guo S; Yang Y; Li Y; Cao J; Ning X; Liu M; Su Y; Sun L; Zhang F; Zhang W
Clin Rheumatol; 2022 Jul; 41(7):2091-2102. PubMed ID: 35348930
[TBL] [Abstract][Full Text] [Related]
2. Predictors for future development of systemic lupus erythematosus in Korean Sjögren's syndrome patients.
Lee BW; Kwon EJ; Park Y; Lee JJ; Ju JH; Park SH; Kwok SK
Lupus; 2023 Oct; 32(12):1359-1368. PubMed ID: 37751679
[TBL] [Abstract][Full Text] [Related]
3. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
[TBL] [Abstract][Full Text] [Related]
4. The proportion of CD161 on CD56
Zhao P; Yang Y; Song S; Cheng W; Peng C; Chang X; Wu J; Liu C
Immun Inflamm Dis; 2024 Apr; 12(4):e1244. PubMed ID: 38577997
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and high-risk indicators of central nervous system involvement in primary Sjögren's syndrome.
Fan W; Par-Young J; Li K; Zhang Y; Xiao P; Hua L; Leng L; Chen X; Bucala R
Clin Rheumatol; 2023 Feb; 42(2):443-451. PubMed ID: 36401063
[TBL] [Abstract][Full Text] [Related]
6. The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjögren's syndrome.
Hsu BC; Chen YH; Lin CH; Tang KT
Int J Rheum Dis; 2022 Dec; 25(12):1424-1430. PubMed ID: 36089698
[TBL] [Abstract][Full Text] [Related]
7. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
8. Anticentromere antibody positive patients with primary Sjögren's syndrome have distinctive clinical and immunological characteristics.
Liu Y; Guo L; Lin W; Ning X; Liu M; Cao J; Su Y; Zheng X; Li S; Li F; Ren L; Song G
Clin Exp Rheumatol; 2023 Dec; 41(12):2371-2378. PubMed ID: 36995331
[TBL] [Abstract][Full Text] [Related]
9. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
Yang Y; Li Z; Wang L; Zhang F
Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
[TBL] [Abstract][Full Text] [Related]
11. Patients with early-onset primary Sjögren's syndrome have distinctive clinical manifestations and circulating lymphocyte profiles.
Wei L; Zhifei X; Xiaoran N; Meilu L; Yang L; Yixuan L; Xiuying R; Yashuang S; Jingjing C; Shaoying G; Liu Y; Lijun S; Fengxiao Z; Wen Z
Rheumatology (Oxford); 2022 Feb; 61(2):597-605. PubMed ID: 33878180
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
13. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0008301 as a potential biomarker of disease activity for primary Sjogren's syndrome: Increased expression in peripheral blood of patients with primary Sjogren's syndrome.
Ji J; Zhang X; Ling Y; Tian J; Wang Y; Luo Y; Zhu R; Zhou Y; Zhu T; Wang L; Zhu H
Int Immunopharmacol; 2022 Nov; 112():109231. PubMed ID: 36113315
[TBL] [Abstract][Full Text] [Related]
15. Ten-year observation of patients with primary Sjögren's syndrome: Initial presenting characteristics and the associated outcomes.
Tsukamoto M; Suzuki K; Takeuchi T
Int J Rheum Dis; 2019 May; 22(5):929-933. PubMed ID: 30588773
[TBL] [Abstract][Full Text] [Related]
16. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjögren's syndrome.
Zhao P; Peng C; Chang X; Cheng W; Yang Y; Shen Y; Sun C; Feng X; Liu C; Wu J
Clin Rheumatol; 2024 Jan; 43(1):297-306. PubMed ID: 37749409
[TBL] [Abstract][Full Text] [Related]
18. Preconception clinical factors related to adverse pregnancy outcomes in patients with systemic lupus erythematosus or primary Sjögren's syndrome: a retrospective cohort study.
Fierro JJ; Prins JR; Verstappen GM; Bootsma H; Westra J; de Leeuw K
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37652559
[TBL] [Abstract][Full Text] [Related]
19. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
20. Predictors of improvement in disease activity in first hospitalized patients with systemic lupus erythematosus: a multicenter retrospective study of a Chinese cohort.
Li M; Liang J; Pan W; Liu L; Wu M; Ding F; Hu H; Ding X; Wei H; Zou Y; Qian X; Wang M; Wu J; Tao J; Tan J; Da Z; Zhang M; Li J; Feng X; Wen L; Zhang H; Sun L
Clin Rheumatol; 2022 Nov; 41(11):3355-3362. PubMed ID: 35849245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
